Distinguished Professor Rutgers University Piscataway, New Jersey
Join Pat Sinko and several authors in Poster Forum #7 in the Solution Center for a conversation about posters that he is especially excited about.
W0930-10-63 Alternative Approach to Demonstrate Bioequivalence of Generic Formulations of Sucralfate Oral Suspension, Manjinder Kaur, Ph.D., US Food and Drug Administration
T1530-02-08 BIONDDTM Oral Capsule Delivery of Liraglutide with Bioavailability Comparable to Subcutaneous Injection and Development of Efficient In Vivo Model in Dogs to Test Feasibility of Other Biologic Drugs, Nina Mertz, Ph.D., Biograil ApS
M1130-02-11 Extended Release Abuse Deterrent Formulation of an Opioid Analgesic, Girish Nihalani, MS, Teva Pharmaceuticals, Inc. (Actavis Inc.)
M1130-11-73 Hydroxypropyl-β-cyclodextrin (HPBCD) in Insoluble Drug-Loaded Nanoparticles Dissolution Studying: A New Approach to Overcoming Sink Limitations, Yihan Wang, MS, University of Maryland Baltimore
W1130-12-82 Mechanistic Modeling of Intramuscular Administration of Long-Acting Injectable Suspensions Accounting for Fibrosis at the Depot Site, Daniela Amaral Amaral Silva, Ph.D., Simulations Plus, Inc.
W1030-04-25 The Estimates for the Absorption Rate Constant in Pharmacokinetics and Pharmacometrics Are Wrong: A New Era Based on the Finite Absorption Time Concept Rises, Panos Macheras, Ph.D., FAAPS, University of Athens